The iconic Bajaj Chetak has once again proven its legacy—this time in the electric avatar. Bajaj Auto has officially announced that its Chetak electric scooter has crossed the 5 lakh sales mark in India, a remarkable feat achieved since its relaunch in January 2020. This milestone reflects not only consumer trust in the brand but also the growing acceptance of electric mobility in the country.
1. Multiple Variants for Every Rider
Bajaj has introduced different versions of the Chetak, offering varied battery packs and features, making it easier for riders to choose according to their needs and budgets.
2. Balanced Pricing Strategy
With models priced between ₹1 lakh and ₹1.35 lakh (ex-showroom), Bajaj has positioned the Chetak as a premium yet affordable EV option compared to rivals.
3. Strong Service & Dealer Network
A key reason behind its rising sales is Bajaj’s vast 3,800+ service touchpoints across India, ensuring riders in Tier-2 and Tier-3 cities don’t hesitate to adopt EVs.
4. Recovery from Supply Challenges
Initial production delays caused by component shortages have been resolved, allowing Bajaj to scale up deliveries and meet the swelling demand.
Bajaj is expected to continue expanding the Chetak lineup with upgraded models offering longer range and smarter features. The brand also plans to push deeper into smaller towns, leveraging its widespread service support to dominate the EV scooter segment.
Crossing the 5 lakh sales milestone is more than just a number for Bajaj—it’s a turning point that proves Indian consumers are ready to embrace sustainable two-wheeler mobility. With demand growing rapidly, the Chetak is not just a scooter anymore—it’s a symbol of India’s EV future.
New draft regulations classify breaches of online money gaming protocols as non-bailable violations, extending accountability…
The Finance Ministry said on Thursday that the Department of Revenue (DoR) has been asked…
Chief Economic Advisor V Anantha Nageswaran underscored the critical need for long-term savings to ensure…
The US private sector unexpectedly shed 32,000 jobs in September, according to ADP, defying analysts’…
Pfizer agreed to lower prescription drug costs for Medicaid and invest $70 billion in US…